Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
See Latest ArticlesMechanisms of resistance to EGFR inhibitors in head and neck cancer
Head & Neck, 04/21/09
Cooper JB et al. - Despite universal EGFR expression in head and neck squamous cell carcinoma, the majority of patients do not respond to EGFR inhibitors. This review focuses on mechanisms of resistance to these agents in HNSCC, and how these may be unique when compared with other malignancies such as non-small cell lung and colorectal cancers.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pediatric cholesteatoma and variants in the gene encoding connexin 26
The Laryngoscope, 11/03/09
Audit of frequent attendees to an ENT emergency clinic
The Journal of Laryngology & Otology, 11/03/09
The nature of fibrous dysplasia
Head & Face Medicine, 11/10/09
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: Results from a phase II prospective trial
Journal of Clinical Oncology, 11/25/09
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Article Search
Sponsor